A rapid production of therapeutic human drugs using modified mushrooms may help mount a quicker response to various public health problems, according to plant pathologists who have received a federal grant to perfect their technique.
C. Peter Romaine, professor of plant pathology at Penn State and holder of the John B. Swayne Chair in Spawn Science, said, "We are looking to address several public health issues through our research."
Romaine and his colleague, Xi Chen, previously a post-doctoral scholar at Penn State, hold the patent to genetically modify Agaricus bisporus – the button variety of mushroom, which is the predominant edible species worldwide.
The Defense Advanced Research Projects Agency (DARPA) recently awarded Penn State and Agarigen Inc., Romaine's spin-off company based in Research Triangle Park in Raleigh, N.C., $2.2 million in initial funding under the Accelerated Manufacture of Pharmaceuticals (AMP) program for the rapid production of vaccines and other therapeutic proteins in altered mushrooms. The total value of the effort, if both phases of the development program are completed, could be up to $5.9 million.
"Our immediate research goals are to maximize the level of expression of various biopharmaceuticals and to devise efficient and economical methods for their extraction and purification from mushroom tissue," Romaine said.
At the end of the second year of the contract, Romaine and his colleagues, who include Agarigen cofounder and former Penn State graduate Dr. Donald S. Walters, Penn State post doctoral associate Dr. Carl Schlagnhaufer and a team of nine Agarigen scientists, are expected to demonstrate an ability to produce vaccines or other biological drugs within 12 weeks.
"It will be a blind test," said Romaine. "We will be handed genes for vaccines, monoclonal antibodies or other therapeutic proteins, and asked to produce them in the mushroom."
The drugs will then be extracted from the mushroom into forms that could be administered to people. In a pending third year of the project, the researchers are expected to show they can execute a full-scale manufacturing effort and produce three million doses of a drug in 12 weeks.
Researchers at Penn State and Agarigen are currently focusing on assembling gene components for expression in the mushroom, and fine-tuning their techniques to ensure a consistently high level and quality of the drug.
"We are evaluating different gene sequences from a broad array of organisms to determine which provide us the highest level of drug expression in the mushroom," explained Romaine. "It is an empirical process, but we are leaving no stone unturned to achieve our end goal."
The Penn State Department of Plant Pathology is at
http://www.ppath.cas.psu.edu/default.html
Source: Penn State
Related stories:
Modified mushrooms may yield human drugs
Mushrooms might serve as biofactories for the production of various beneficial human drugs, according to plant pathologists who have inserted new genes into mushrooms.
Discovering a new life form in the hot springs of Yellowstone
Geysers, mud pots, steam vents and hot springs in the region now known as Yellowstone National Park awed American Indians and early European explorers. Now, two million tourists visit the park in northwestern Wyoming each year to watch wildlife and view the spectacular scenery. Scientists home in on the hot springs, exploring their ecology and plumbing their scalding waters in search of highly adapted, heretofore-undiscovered microorganisms.
Surprising new species of light-harvesting bacterium discovered in Yellowstone
In the hot springs of Yellowstone National Park, a team of researchers has discovered a novel bacterium that transforms light into chemical energy.
Mushrooms as good an antioxidant source as more colorful veggies
Portabella and crimini mushrooms rank with carrots, green beans, red peppers and broccoli as good sources of dietary antioxidants, Penn State researchers say.
Sleepy Fruit Flies Provide Clues to Learning and Memory
Researchers at the University of Pennsylvania School of Medicine have discovered that a brain region previously known for its role in learning and memory also serves as the location of sleep regulation in fruit flies. Through further examination of this brain structure, researchers hope to shed light on sleep regulation and its role in memory.
Probing Question: What do astronauts eat in space?
Freeze-dried cubes and unpleasant powders? Try shrimp cocktail and butterscotch pudding. These are only a couple of the items now on the galactic menu thanks to NASA's Food Technology Commercial Space Center (FTCSC), located at Iowa State University. Here, food scientists, nutritionists, engineers, and plant breeders are collaborating to develop nutritious, convenient, safe, and tasty foods for outer space consumption. Koushik Seetharaman, assistant professor in the department of food science at Penn State, is part of the team.
Probing Question: Did Shakespeare really write all those plays?
“Done to death by slanderous tongues.” So wrote William Shakespeare in his play, Much Ado About Nothing. Or did he? Even people who have never actually read Shakespeare have heard the theories: Shakespeare’s plays were written by Francis Bacon! Shakespeare’s plays were written by the Earl of Oxford! Shakespeare’s plays were written by anyone, anyone, but William Shakespeare!
Geochemical processes go high-tech in 3-D, interactive project
(PhysOrg.com) -- They occur constantly, are largely invisible but affect everything from energy supplies and soil erosion to water pollution.